Abstract

As a member of Sirtuins family, SIRT6 participates in the physiological and pathological progress of DNA repair, anti-aging, metabolism, and so on. Several studies have demonstrated that knockdown of SIRT6 inhibited the development of atherosclerosis (AS), indicated SIRT6 as a protective factor for AS. However, we confirmed SIRT6 was significantly overexpressed in human unstable carotid plaques compared with stable carotid plaques. This result indicated a more complex role of SIRT6 in AS. Furthermore, we constructed mice model with unstable carotid plaque and injected them with SIRT6 overexpressed adeno-associated virus (AAV-SIRT6). AAV-SIRT6 significantly promoted angiogenesis as well as hemorrhage in plaques. In vitro, we demonstrated overexpression of SIRT6 prevented HIF-1α from degradation by deubiquitination at K37 and K532 of HIF-1α, thus promoted the expression of HIF-1α under both normoxia and hypoxia in human umbilical vein endothelial cells (HUVECs). Through regulating HIF-1α, overexpression of SIRT6 promoted invasion, migration, proliferation, as well as tube formation ability of HUVECs. Interestingly, under different conditions, SIRT6 played different roles in the function of HUVECs. Under oxidative stress, another important pathological environment for AS, SIRT6 bound to the promoter of Catalase, a main reactive oxygen species scavenger, and depleted H3K56 acetylation, thus inhibited expression and activity of Catalase at the transcriptional level. Subsequently, inhibited Catalase promoted reactive oxygen species (ROS) under oxidative stress. Accumulated ROS further aggravated oxidative stress injury of HUVECs. On one hand, SIRT6 promoted angiogenesis in plaque via HIF-1α under hypoxia. On the other hand, SIRT6 promoted injury of neovascular via ROS under oxidative stress. It is this process of continuous growth and damage that leads to hemorrhage in carotid plaque. In conclusion, we innovatively confirmed SIRT6 promoted the angiogenesis and IPH via promoting HIF-1α and ROS in different environments, thus disclosed the unknowing danger of SIRT6.

Highlights

  • Cardiovascular disease is the leading killer of human death, in which AS is the ringleader

  • We comprehensively investigated the role of SIRT6 from clinical specimens, human umbilical vein endothelial cells (HUVECs) under different conditions, as well as unstable carotid plaque mice model to learn the effect of SIRT6 at carotid AS

  • We first measured the expression of SIRT6 in stable and unstable carotid plaques derived from carotid endarterectomy (CEA), respectively

Read more

Summary

Introduction

Cardiovascular disease is the leading killer of human death, in which AS is the ringleader. Carotid AS accounts for about 25% of all atherosclerotic lesions, Plaque neovascularization and accompanied intraplaque hemorrhage (IPH) is an important histological feature of unstable plaques, whereas the molecular mechanism of them remains unclear[2,3]. The Sirtuins family is Class III deacetylases relying on nicotinamide adenine (NAD+). They play important roles in metabolism, aging, and so on. SIRT6 is a nuclear histone deacetylase that targets H3K56ac and H3K9ac[4,5].

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call